Application 091008
- Type
- ANDA
- Sponsor
- JIANGSU HENGRUI MED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 100MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 300MG | No | No |
| 003 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091008-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A091008-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Exelan Pharmaceuticals, Inc. | a88edb00-2189-4c8d-9dd7-9fe1571775cc | 2025-08-16 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 707ed63a-67ca-4a62-9cbe-cdeb5c4ab506 | 2025-08-16 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | XLCare Pharmaceuticals, Inc. | 618c948d-deee-44e2-98f0-e5232171dd50 | 2025-08-04 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | ca8177ed-1f0d-436e-a5ac-f58b8f7cbb25 | 2025-07-28 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 2278ce1b-1c19-4ad2-89c6-4530f7b78ea7 | 2025-07-14 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | 9508cb1b-3f9f-48bd-8f34-a6fbb68c9a4a | 2025-07-11 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 3f2e3ac5-5233-fd57-e063-6294a90a849e | 2025-07-01 | Warnings, Adverse reactions | gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 7c3b232a-3e9f-4249-9e5a-295482ee288a | 2025-06-27 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | NorthStar Rx LLC | f7c1fd34-d615-43a2-8989-898fe11f90df | 2025-06-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | d25daaac-a8ab-4f12-acc2-4ec8fc97a2d4 | 2025-06-24 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | QUALLENT PHARMACEUTICALS HEALTH LLC | 472bb279-bb4e-4246-b2a3-172483ba356b | 2025-06-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 5d3f27bf-3486-40fa-a4d3-5f0b2c6c0151 | 2025-06-11 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 561f53d5-5301-42b3-b372-f3d49d642a2e | 2025-06-11 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Direct_Rx | ed9c501c-24e4-da89-e053-2a95a90a64c6 | 2025-06-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 11645bd6-7cfe-49b2-9292-2e4b0dbb84ae | 2025-06-04 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 969cccfc-e56a-49da-9d36-47c0c3fad7f8 | 2025-06-03 | Warnings, Adverse reactions | gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | PAI Holdings, LLC dba PAI Pharma | 6d3fd1f9-c831-4262-af10-291838a53541 | 2025-05-31 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Rising Pharma Holdings, Inc. | 8215da86-d7af-4980-b6d6-4bd46f6bfeaf | 2025-05-30 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | ATLANTIC BIOLOGICALS CORP. | 5969f1a8-d6d5-4967-add5-4e2492354d7b | 2025-05-27 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | 0ce53f62-1738-43f4-9a2e-c5dc42a91d09 | 2025-05-26 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |